Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium for Intracranial Hypertension in Severe TBI
NCT02404779Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Mar 2015
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in intracranial hypertension (IH) comparing Cisatracurium Arm with Placebo Arm (2 arms). Primary endpoint: Area under the curve of the temporal evolution of intracranial pressure at 30 minutes. Status: unknown.
02
Drugs
cisatracurium
03
Conditions
intracranial hypertension (IH)
Beyond the preview
Go deeper on NCT02404779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404779.